NOX4 and diabetic neuropathy: The inhibition of NOX-4 by daidzein decreases the production of reactive oxygen species (ROS), which are key contributors to inflammation and oxidative stress in diabetic neuropathy (Kallenborn-Gerhardt et al., 2012; Geng et al., 2015).